Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
RCUS | US
Overview
Corporate Details
- ISIN(s):
- US03969F1093
- LEI:
- Country:
- United States of America
- Address:
- 3928 POINT EDEN WAY, 94545 HAYWARD
- Website:
- https://arcusbio.com/
- Sector:
- Manufacturing
Description
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer. The company's approach centers on creating both small molecules and antibodies designed to be combined for greater efficacy. Its pipeline of investigational medicines is guided by specific biologic mechanisms of cancer, with a strategy aimed at accelerating the development of novel combination treatments from early-stage clinical studies through to potential commercialization. Arcus Biosciences collaborates with the broader cancer community to advance its global clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Arcus Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Arcus Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Arcus Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
